RNA Therapeutics for Treatment of Cardiovascular Diseases

2016/09/15 by Tina Lucas, Stefanie Dimmeler · 7 citations
Biochemistry, Genetics and Molecular Biology · #Cancer-related molecular mechanisms research #RNA modifications and cancer #MicroRNA in disease regulation

paper · pdf · doi:10.1161/circresaha.116.308730

Cited by

• MicroRNA-regulated pathways of flow-stimulated angiogenesis and vascular remodeling in vivo. [europepmc]
• Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart. [europepmc]
• MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus). [europepmc]
• Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease. [europepmc]
• Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy. [europepmc]
• Vaccine Formulation Strategies and Challenges Involved in RNA Delivery for Modulating Biomarkers of Cardiovascular Diseases: A Race from Laboratory to Market. [europepmc]
• Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management. [europepmc]